Cardiologist Derek Connolly flags a comparison of pill and injection versions of incretin drugs as worth reading. Tap through for the analysis.
Recap by typeshit. Post by Prof Derek Connolly on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Fox News reports semaglutide and tirzepatide may help joints, inflammation and organs ahead of any weight change, per the research it cites.
Fox News reports that semaglutide and tirzepatide may ease joint pain, inflammation and organ strain early in treatment, before much weight comes off.
Loading…